Dyne Therapeutics (DYN)
Nasdaq • DYN • US26818M1080
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 13.9% of free float sold short, 8.3 days to cover, cost to borrow 0.51%. Sign up for live short interest data.
Market Cap
3.36b USD | # 3054 in US
Volume
2.85m shares | 55.3m USD
Shares Outstanding
187.39m
Free Float Shares
99.73% | 186.88m
